American Academy of Pediatrics (AAP)
FDARulemakingFDA-2025-N-1360

Over-the-Counter Monograph Procedure for Minor Changes C001: Minor Changes to Solid Oral Dosage Forms for Certain Over-the-Counter Monograph Drugs

RIN
Last modified
Oct 9, 2025
Comment window
closed 298d ago
American Academy of Pediatrics (AAP) filings
1

Activity

American Academy of Pediatrics (AAP) filed 1 comment on this docket between Oct 9, 2025 and Oct 9, 2025. 1 other organizations filed here. The comment window closed 298d ago.

What American Academy of Pediatrics (AAP) filed (1)

Oct 9, 2025· Comment from American Academy of Pediatrics· FDA-2025-N-1360-0006

Filed on regulations.gov — full text not in the inline record.

Abstract

The Food and Drug Administration (FDA) is announcing the availability on its website of the proposed administrative order (proposed order) (OTC000038) entitled “Over-the-Counter Monograph Procedure for Minor Changes C001: Minor Changes to Solid Oral Dosage Forms for Certain Over-the-Counter Monograph Drugs.” This proposed order, if finalized, will permit minor changes in the dosage form, i.e., from tablets and capsules to chewable tablets, orally disintegrating tablets, or films, of over-the-counter (OTC) monograph drugs that are in conformity with the requirements of the order, the Federal Food, Drug, and Cosmetic Act (FD&C Act), and other applicable requirements, without the issuance of a separate order amending an applicable OTC monograph to add the new dosage form or otherwise finding the new dosage form to be generally recognized as safe and effective (GRASE).

View on regulations.gov →